17-Jan-2026 2:43 AM CST - Yahoo Finance Is DaVita (DVA) Pricing In Its Recent 37% One Year Share Price Gain? If you are wondering whether DaVita's current share price fairly reflects its long term potential, you are not alone. This article will walk through what the market may be pricing in and what it might be missing.
20-Dec-2025 2:33 AM CST - Yahoo Finance DaVita (DVA): Reassessing Valuation After a 23% Year-to-Date Share Price Decline DaVita (DVA) has quietly slipped this year, with the stock down about 23% year to date and roughly 24% over the past year, despite steady revenue and earnings growth. See our latest analysis for DaVita.
11-Dec-2025 1:40 PM CST - Yahoo Finance Is DaVita Attractive After a 21% Drop in 2025 Amid Policy Uncertainty? If you are wondering whether DaVita at around $118 a share is a bargain or a value trap, you are not alone. This breakdown is designed to help you assess the situation with more confidence. The stock is roughly flat over the last week,
11-Dec-2025 7:22 AM CST - Yahoo Finance DaVita Names New Leaders to Accelerate Care Transformation DaVita, a leading provider of kidney care services, today announced two key additions to its executive leadership team: Stephanie Hendrickson has been named Chief People Officer (CPO) and Steve Phillips will serve as Chief Strategy Officer (CSO),
3-Dec-2025 7:30 AM CST - Seeking Alpha DaVita: More Volatile But Better Upside Than Fresenius DaVita (DVA) is rated a speculative 'Buy,' reflecting undervaluation despite recent earnings volatility. DVA's moat stems from its dominant US dialysis clinic network, but its reliance on Medicare reimbursement and lack of dividend heighten risk.
29-Nov-2025 8:57 AM CST - Yahoo Finance A Look at DaVita's Valuation Following New $3.5 Billion Credit Agreement DaVita (DVA) just finalized an amended credit agreement that brings in a $2 billion five-year term loan and a $1.5 billion revolving credit facility. This refinancing not only repays previous debt, but also offers additional financial flexibility for corporate needs.
22-Nov-2025 11:59 AM CST - Yahoo Finance Evaluating DaVita Stock After a 27.3% Drop This Year Wondering if DaVita stock is trading at a bargain or an inflated premium? You are not alone, especially with so much chatter about where opportunities really lie in this market. Despite impressive gains of 62.
17-Jan-2026 2:43 AM CST - Yahoo Finance Is DaVita (DVA) Pricing In Its Recent 37% One Year Share Price Gain? If you are wondering whether DaVita's current share price fairly reflects its long term potential, you are not alone. This article will walk through what the market may be pricing in and what it might be missing.
20-Dec-2025 2:33 AM CST - Yahoo Finance DaVita (DVA): Reassessing Valuation After a 23% Year-to-Date Share Price Decline DaVita (DVA) has quietly slipped this year, with the stock down about 23% year to date and roughly 24% over the past year, despite steady revenue and earnings growth. See our latest analysis for DaVita.
11-Dec-2025 1:40 PM CST - Yahoo Finance Is DaVita Attractive After a 21% Drop in 2025 Amid Policy Uncertainty? If you are wondering whether DaVita at around $118 a share is a bargain or a value trap, you are not alone. This breakdown is designed to help you assess the situation with more confidence. The stock is roughly flat over the last week,
11-Dec-2025 7:22 AM CST - Yahoo Finance DaVita Names New Leaders to Accelerate Care Transformation DaVita, a leading provider of kidney care services, today announced two key additions to its executive leadership team: Stephanie Hendrickson has been named Chief People Officer (CPO) and Steve Phillips will serve as Chief Strategy Officer (CSO),
3-Dec-2025 7:30 AM CST - Seeking Alpha DaVita: More Volatile But Better Upside Than Fresenius DaVita (DVA) is rated a speculative 'Buy,' reflecting undervaluation despite recent earnings volatility. DVA's moat stems from its dominant US dialysis clinic network, but its reliance on Medicare reimbursement and lack of dividend heighten risk.
29-Nov-2025 8:57 AM CST - Yahoo Finance A Look at DaVita's Valuation Following New $3.5 Billion Credit Agreement DaVita (DVA) just finalized an amended credit agreement that brings in a $2 billion five-year term loan and a $1.5 billion revolving credit facility. This refinancing not only repays previous debt, but also offers additional financial flexibility for corporate needs.
22-Nov-2025 11:59 AM CST - Yahoo Finance Evaluating DaVita Stock After a 27.3% Drop This Year Wondering if DaVita stock is trading at a bargain or an inflated premium? You are not alone, especially with so much chatter about where opportunities really lie in this market. Despite impressive gains of 62.
